Blood Screening Market Size is Expected to Reach USD 5.16 Billion in 2030 – Reports and Data
The global blood screening market size was USD 2.50 Billion in 2021 and is expected to register a revenue CAGR of 8.4% over the forecast period, according to the latest report by Reports and Data. Market revenue growth is primarily driven by development of new methods for detecting bloodstream pathogens. In addition, rising prevalence of new pathogens, increasing public health awareness, rising number of blood donations, and surge in Nucleic Acid Amplification Testing (NAT) are other factors driving revenue growth of the market. Pathogen inactivation is an active strategy to inactivate pathogens before they enter the blood supply. Vast majority of pathogen inactivation techniques concentrate on nucleic acids and allow for inactivation of a wide range of pathogens including nucleic acids in plasma, platelets, or red blood cells, potentially lowering risk of sickness associated with transfusion. Blood transfusions save lives and improve health, but many patients who need them do not have timely access to safe blood. In addition, strict government rules and regulations in each country for provision of safe and adequate blood are expected to facilitate adoption of blood testing in blood banks and medical facilities. Moreover, WHO also recommends that all activities related to collection, testing, processing, storage, and distribution of blood should be coordinated at the national level through effective organizations and integrated blood supply networks. Furthermore, national blood system is governed by a national blood policy and legal framework to promote uniformity and consistent implementation of standards in the quality and safety of blood and blood products. These factors are expected to drive market revenue growth.
To get a sample copy of the report, click on @ https://www.reportsanddata.com/download-free-sample/3458
Top Companies Profiled in the Report:
- GE Healthcare
- Hoffmann-La Roche Ltd.
- Thermo Fisher Scientific Inc.
- Procter & Gamble
- Ortho Clinical Diagnostics Inc.
- Bio-Rad Laboratories Inc.
- Enzo Biochem Inc.
- Reagents & Kits
- NAT Reagents & Kits
- ELISA Reagents & Kits
- Software and Services
- Western Blot Assays
- Rapid Tests
- Next-generation Sequencing
The global pharma & healthcare market revenue growth majorly driven by factors such as increasing prevalence of chronic and acute illnesses around the world, substantially growing patient pool, rise in demand for personalized medicine, increasing pharmaceutical and biotechnological research & development projects, and rapid incorporation of emerging technologies such as artificial intelligence (AI), Internet of Things (IoT), big data analytics, robotics, and blockchain in healthcare. Rising cases of COVID-19 worldwide, surge in demand for advanced healthcare services during the COVID-19 pandemic, growing trends of telehealth and telemedicine, rising demand for advanced point-of-care diagnostics, and increasing government and private funding for development of COVID-19 vaccines are other key factors driving market revenue growth. Furthermore, increasing investments in new drug discovery & development and rising government focus on reinforcing the healthcare supply chain to meet growing medical needs are factors boosting revenue growth of this market.
To know more about the report, visit @ https://www.reportsanddata.com/report-detail/blood-screening-market
Table of Contents (ToC) – Global Blood Screening Market
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.4. Research Sources
1.4.1. Primary Sources
1.4.2. Secondary Sources
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2020-2030
Chapter 3. Key Insights
Chapter 4. Global Pharma & Healthcare Market Segmentation
4.1. Global Pharma & Healthcare Market COVID-19 Impact Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers’ analysis
4.2.3. Market restraints analysis
4.3. Technological Insights
4.4. Porter’s Five Forces Analysis
4.5. Regulatory Framework
4.6. Price trend Analysis
4.7. Competitive Metric Space Analysis
Key Regional Markets Covered in the Report:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Spain, France, BENELUX, Rest of Europe)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of Asia Pacific)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- The Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Request customization of the report @ https://www.reportsanddata.com/request-customization-form/3458
Thank you for reading our report. Do connect with us in case of any more queries about the report and its customization. Our team will ensure the report is well suited to cater to your needs.
Get Explore Latest Research Report by Reports and Data:
Acute Exacerbation of CRS Treatment Market @ https://www.biospace.com/article/acute-exacerbation-of-crs-treatment-market-size-share-top-key-players-growth-trend-and-forecast-till-2028/
Pediatric Radiology Market @ https://www.biospace.com/article/pediatric-radiology-market-share-comprehensive-analysis-opportunity-assessment-future-estimations-and-key-industry-segments-poised-for-strong-growth-in-future-2028/
Frozen Food Packaging Market @ https://www.prnewswire.com/news-releases/frozen-food-packaging-market-size-to-reach-usd-60-58-billion-in-2028-technological-advancements-in-the-packaging-industry-is-a-key-factor-driving-growth-of-the-frozen-food-packaging-market-says-reports-and-data-301340859.html
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]